SPEX Profile
Spherix Incorporated (SPEX) is a publicly-traded intellectual property development company that focuses on monetizing patents and technology IP. The company's operations are primarily focused on acquiring, developing, and monetizing intellectual property assets in the technology, communications, and life sciences sectors.
Spherix's IP portfolio includes over 150 patents, including patents related to wireless communications, mobile communication devices, and telecommunication protocols. The company also owns patents related to cancer treatments and antiviral agents.
Spherix has pursued a variety of strategies to monetize its IP portfolio, including licensing, partnerships, and litigation. The company has filed patent infringement lawsuits against several high-profile companies, including Google, Verizon, and Cisco Systems.
In addition to its IP monetization activities, Spherix has also invested in several start-up companies in the life sciences and technology sectors. The company has also explored potential acquisitions and strategic partnerships to expand its IP portfolio and monetization opportunities.
However, Spherix has faced some challenges in its efforts to monetize its IP portfolio, including legal fees associated with patent litigation and difficulty in finding licensing partners. The company has also faced fluctuations in its stock price, which has been impacted by the outcomes of its legal battles and market fluctuations.
Overall, Spherix is an IP development company that is focused on monetizing its patent portfolio in the technology, communications, and life sciences sectors. While the company has faced some challenges in its efforts to monetize its IP assets, it continues to pursue a variety of strategies to generate value for its shareholders.
|
